Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD

Respiratory Medicine

Volumn 105, Issue 3, 2011, Pages 329-336

  Wu, Lian ^a   Ma, Li ^a   Nicholson, Louise F B ^a   Black, Peter N ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Advanced glycation end products; Chronic obstructive pulmonary disease; Immunohistochemistry; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG CARCINOMA; LUNG PARENCHYMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; SMOKING;

AGING; CELLS, CULTURED; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; LUNG; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; SMOKING;

EID: 79151480125     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.11.001     Document Type: Article

References (42)

1. R. Bucala, and A. Cerami Advanced glycosylation: chemistry, biology, and implication for diabetes and ageing Adv Pharmacol 23 1992 1 34
2. R. Bucala, H. Vlassara, and A. Cerami Advanced glycosylation end products J.J. Harding, M. James, C. Crabbe, Post translational modifications of proteins 1992 CRC Press Boca Raton, Ann Arbor, London 53 79
3. A.M. Schmidt, S.D. Yan, and S.F. Yan The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949 955
4. C. Ryle, and M. Donaghy Non-enzymatic glycation of peripheral nerve proteins in human diabetics J Neurol Asci 129 1995 62 68
5. J.M. Forbes, T. Soulis, V. Thallas, S. Panagiotopoulos, D.M. Long, and S. Vasan Renoprotective effects of a novel inhibitor of advanced glycation Diabetologia 44 2001 108 114
6. G. Perry, R.J. Castellani, K. Hirai, and M.A. Smith Reactive oxygen species mediate cellular damage in Alzheimer disease J Alzheimers Dis 1 1 1998 Mar 45 55
7. S. Dukic-Stefanovic, R. Schinzel, P. Riederer, and G. Münch AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology 2 1 2001 19 34
8. C. Fletcher, and R. Peto The natural history of chronic airflow obstruction BMJ 1 1977 1645 1648
9. I.D. Nicholl, A.W. Stitt, J.E. Moore, A.J. Ritchie, D.B. Archer, and R. Bucala Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers Mol Med 4 9 1998 Sep 594 601
10. S. Daoud, R. Schinzel, A. Neumann, C. Loske, D. Fraccarollo, C. Diez, and A. Simm Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts Mol Med 7 8 2001 Aug 543 551
11. M. Neeper, A.-M. Schmidt, J. Brett, and S.D. Yan Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of proteins J Biol Chem 267 1992 14998 15004
12. A. Bierhaus, K.M. Haslbeck, M. Morcos, S. Schiekofer, M. Andrassy, J. Chen, T. Dehner, B. Neundörfer, W. Möller, H. Trischler, M. Schwaiger, D. Heuss, H.U. Häring, E. Schleicher, and P.P. Nawroth Hyperglycaemia increases CML deposition, RAGE expression and NFkappaB activation in peripheral nerves Exp Clin Endocrinol Diabetes 108 2000 122
13. B.M. Dattilo, G. Fritz, E. Leclerc, C.W. Kooi, C.W. Heizmann, and W.J. Chazin The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units Biochemistry 46 2007 6957 6970
14. M.A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M.F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, and A.M. Schmidt RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
15. N. Demling, C. Ehrhardt, M. Kasper, M. Laue, L. Knels, and E.P. Rieber Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells Cell Tissue Res 323 3 2006 Mar 475 488 Epub 2005 Nov 29
16. M. Saetta CD8+ T lymphocytes in the peripheral airways of smokers with chronic obstructive pulmonary disease Am J Respir Crit Care 157 1998 822 826
17. T.K. Mukherjee, S. Mukhopadhyay, and J.R. Hoidal Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology Respir Physiol Neurobiol 162 3 2008 Aug 31 210 215 Epub 2008 Jul 11. Review. PubMed PMID: 18674642
18. N. Ferhani, S. Letuve, A. Kozhich, O. Thibaudeau, M. Grandsaigne, M. Maret, M.C. Dombret, G.P. Sims, R. Kolbeck, A.J. Coyle, M. Aubier, and M. Pretolani Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 9 2010 May 1 917 927 Epub 2010 Feb 4. PubMed PMID: 20133931
19. B. Bartling, C. Fuchs, V. Somoza, B. Niemann, R.E. Silber, and A. Simm Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo Mol Nutr Food Res 51 4 2007 Apr 479 487 PubMed PMID: 17357979
20. T. Koschinsky, C.J. He, T. Mitsuhashi, R. Bucala, C. Liu, C. Buenting, K. Heitmann, and H. Vlassara Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy Proc Natl Acad Sci USA 94 12 1997 6474 6479 10.1073/pnas.94.12.6474 PMID 9177242. PMC 21074
21. Y. Yamamoto, I. Kato, T. Doi, and H. Yonekura Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice J Clin Invest 108 2001 261 268
22. T. Sakaguchi, S.F. Yan, S.D. Yan, and D. Belov Central role of RAGE-dependent neointimal expansion in arterial restenosis J Clin Invest 111 2003 959 972
23. B. Liliensiek, M.A. Weigand, A. Bierhaus, and W. Nicklas Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 2004 1641 1650
24. K.G. Raman, P.L. Sappington, R. Yang, and R.M. Levy The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock Am J Physiol Gastrointest Liver Physiol 291 2006 G556 G565
25. R. Deane, S. Du Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, and B. Zlokovic RAGE mediates amyloidbeta peptide transport across the blood-brain barrier and accumulation in brain Nat Med 9 2003 907 913
26. Y. Naka, L.G. Bucciarelli, T. Wendt, L.K. Lee, L.L. Rong, R. Ramasamy, S.F. Yan, and A.M. Schmidt RAGE axis: animal models and novel insights into the vascular complications of diabetes Arterioscler Thromb Vasc Biol 24 2004 1342 1349
27. J.M. Englert, L.E. Hanford, N. Kaminski, J.M. Tobolewski, R.J. Tan, C.L. Fattman, L. Ramsgaard, T.J. Richards, I. Loutaev, P.P. Nawroth, M. Kasper, A. Bierhaus, and T.D. Oury A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis Am J Pathol 172 3 2008 Mar 583 591 Epub 2008 Feb 2
28. M.A. Queisser, F.M. Kouri, M. Königshoff, M. Wygrecka, U. Schubert, O. Eickelberg, and K.T. Preissner Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types Am J Respir Cell Mol Biol 39 3 2008 Sep 337 345 Epub 2008 Apr 17. PubMed PMID: 18421017
29. T. Uchida, M. Shirasawa, L.B. Ware, K. Kojima, Y. Hata, K. Makita, G. Mednick, Z.A. Matthay, and M.A. Matthay Receptor for advanced glycation endproducts is a marker of type I cell injury in acute lung injury Am J Respir Crit Care Med 173 2006 1008 1015
30. D. Foell, S. Seeliger, T. Vogl, H.G. Koch, H. Maschek, E. Harms, C. Sorg, and J. Roth Expression of S100A12 (EN-RAGE) in cystic fibrosis Thorax 58 2003 613 617
31. P. Morbini, C. Villa, I. Campo, M. Zorzetto, S. Inghilleri, and M. Luisetti The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 19 11 2006 Nov 1437 1445 Epub 2006 Aug 25
32. M.P. Wautier, O. Chappey, S. Corda, D.M. Stern, A.M. Schmidt, and J.L. Wautier Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE Am J Physiol Endocrinol Metab 280 2001 E685 E694
33. H. Yao, I. Edirisinghe, S.R. Yang, S. Rajendrasozhan, A. Kode, S. Caito, D. Adenuga, and I. Rahman Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice Am J Pathol 172 5 2008 May 1222 1237 Epub 2008 Apr 10
34. S. Dukic-Stefanovic, J. Gasic-Milenkovic, W. Deuther-Conrad, and G. Münch Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs) J Neurochem 87 2003 44 55
35. Z. Wang, J. Xu, J.Y. Zhou, Y. Liu, and G.S. Wu Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance Cancer Res 66 2006 8870 8877
36. J. Liu, S. Zhao, J. Tang, Z. Li, T. Zhong, Y. Liu, D. Chen, M. Zhao, Y. Li, X. Gong, P. Deng, J.H. Wang, and Y. Jiang Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB FEBS J 276 16 2009 Aug 4598 4606 Epub 2009 Jul 23. PubMed PMID: 19645720
37. L.J. Sparvero, D. Asafu-Adjei, and R. Kang RAGE (Receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation J Transl Med 7 2009 1 21 article 17
38. A. Wong, S. Dukic-Stefanovic, J. Gasic-Milenkovic, R. Schinzel, H. Wiesinger, P. Riederer, and G. Münch Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia Eur J Neurosci 14 2001 1961 1967
39. A. Bierhaus, P.M. Humpert, and M. Morcos Understanding RAGE, the receptor for advanced glycation end products J Mol Med 83 2005 876 886
40. A. Bierhaus, S. Schiekofer, and M. Schwaninger Diabetes associated sustained activation of the transcription factor nuclear factor-kappaB Diabetes 50 2001 2792 2808
41. Y. Higashimoto, Y. Yamagata, S. Taya, T. Iwata, M. Okada, T. Ishiguchi, H. Sato, and H. Itoh Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences Respirology 13 1 2008 Jan 128 133
42. M.P. Foschino Barbaro, G.E. Carpagnano, A. Spanevello, M.G. Cagnazzo, and P.J. Barnes Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease Int J Immunopathol Pharmacol 20 4 2007 Oct-Dec 753 763